Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henit Yanai

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|February 22, 2022
Perianal Crohn Disease Is More Common in Children and Is Associated With Complicated Disease Course Despite Higher Utilization of Biologics: A Population-based Study From The epidemiology group of the Israeli IBD Research Nucleus (epiIIRN)Ohad Atia, Gili Focht, Rona Lujan, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 20, 2023
Dysplasia detection rates under a surveillance program in a tertiary referral center for inflammatory bowel diseases: Real-world dataYifat Snir, Jacob E Ollech, Noam Peleg, et al.
Journal of Clinical Medicine|June 28, 2023
Pregnancy Outcomes in a Cohort of Patients with Inflammatory Bowel Disease: Data from a Multidisciplinary Clinic in a Tertiary CenterIrit Avni Biron, Lior Hayat, Jacob E Ollech, et al.
Alimentary Pharmacology & Therapeutics|March 9, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort studyOhad Atia, Idan Goren, Tali Sharar Fischler, et al.
NPJ Science of Food|June 29, 2026
Aligning patient and planetary health: planetary health diet adherence and inflammatory bowel disease prognosis across Western and Eastern cohortsLintao Dan, Haiting Shu, Yuhao Sun, et al.
The American Journal of Gastroenterology|December 23, 2022
Patency Capsule: A Novel Independent Predictor for Long-Term Outcomes Among Patients With Quiescent Crohn's DiseaseOffir Ukashi, Uri Kopylov, Bella Ungar, et al.
Inflammatory Bowel Diseases|April 21, 2023
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRNOhad Atia, Ramit Magen Rimon, Natan Ledderman, et al.
Journal of Clinical Gastroenterology|April 22, 2021
Exploring Popular Social Media Networks for Patients With Inflammatory Bowel Diseases: Insights for Better CareIdan Goren, Gal Sharvit, Lihi Godny, et al.
World Journal of Gastroenterology|February 17, 2015
Significance of low level infliximab in the absence of anti-infliximab antibodiesBella Ungar, Adi Anafy, Henit Yanai, et al.
Therapeutic Advances in Gastroenterology|January 27, 2022
Risk of consecutive immunogenic failure in switchers of anti-tumor necrosis factor alpha among patients with inflammatory bowel diseasesHenit Yanai, Bella Ungar, Uri Kopylov, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
Journal of Pediatric Gastroenterology and Nutrition|February 22, 2022
Perianal Crohn Disease Is More Common in Children and Is Associated With Complicated Disease Course Despite Higher Utilization of Biologics: A Population-based Study From The epidemiology group of the Israeli IBD Research Nucleus (epiIIRN)Ohad Atia, Gili Focht, Rona Lujan, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 20, 2023
Dysplasia detection rates under a surveillance program in a tertiary referral center for inflammatory bowel diseases: Real-world dataYifat Snir, Jacob E Ollech, Noam Peleg, et al.
Journal of Clinical Medicine|June 28, 2023
Pregnancy Outcomes in a Cohort of Patients with Inflammatory Bowel Disease: Data from a Multidisciplinary Clinic in a Tertiary CenterIrit Avni Biron, Lior Hayat, Jacob E Ollech, et al.
Alimentary Pharmacology & Therapeutics|March 9, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort studyOhad Atia, Idan Goren, Tali Sharar Fischler, et al.
NPJ Science of Food|June 29, 2026
Aligning patient and planetary health: planetary health diet adherence and inflammatory bowel disease prognosis across Western and Eastern cohortsLintao Dan, Haiting Shu, Yuhao Sun, et al.
The American Journal of Gastroenterology|December 23, 2022
Patency Capsule: A Novel Independent Predictor for Long-Term Outcomes Among Patients With Quiescent Crohn's DiseaseOffir Ukashi, Uri Kopylov, Bella Ungar, et al.
Inflammatory Bowel Diseases|April 21, 2023
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRNOhad Atia, Ramit Magen Rimon, Natan Ledderman, et al.
Journal of Clinical Gastroenterology|April 22, 2021
Exploring Popular Social Media Networks for Patients With Inflammatory Bowel Diseases: Insights for Better CareIdan Goren, Gal Sharvit, Lihi Godny, et al.
World Journal of Gastroenterology|February 17, 2015
Significance of low level infliximab in the absence of anti-infliximab antibodiesBella Ungar, Adi Anafy, Henit Yanai, et al.
Therapeutic Advances in Gastroenterology|January 27, 2022
Risk of consecutive immunogenic failure in switchers of anti-tumor necrosis factor alpha among patients with inflammatory bowel diseasesHenit Yanai, Bella Ungar, Uri Kopylov, et al.
Pageof 13